206 related articles for article (PubMed ID: 20012908)
1. Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection.
Parkins MD; Gregson DB; Pitout JD; Ross T; Laupland KB
Infection; 2010 Feb; 38(1):25-32. PubMed ID: 20012908
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
4. Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa.
Hattemer A; Hauser A; Diaz M; Scheetz M; Shah N; Allen JP; Porhomayon J; El-Solh AA
Antimicrob Agents Chemother; 2013 Aug; 57(8):3969-75. PubMed ID: 23733476
[TBL] [Abstract][Full Text] [Related]
5. Clinical findings of bacteremic septic arthritis according to the site of acquisition: The overlap between health care-related and community- and nosocomial-acquired cases.
Murillo O; Gomez-Junyent J; Grau I; Ribera A; Cabrera C; Pedrero S; Tubau F; Nolla JM; Ariza J; Pallares R
Eur J Intern Med; 2016 Mar; 28():38-42. PubMed ID: 26639050
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006.
Leal J; Gregson DB; Ross T; Church DL; Laupland KB
J Infect; 2008 Sep; 57(3):198-203. PubMed ID: 18672296
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors.
Grisaru-Soen G; Lerner-Geva L; Keller N; Berger H; Passwell JH; Barzilai A
Pediatr Infect Dis J; 2000 Oct; 19(10):959-63. PubMed ID: 11055596
[TBL] [Abstract][Full Text] [Related]
8. Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.
Tsakris A; Poulou A; Kristo I; Pittaras T; Spanakis N; Pournaras S; Markou F
J Clin Microbiol; 2009 Nov; 47(11):3524-9. PubMed ID: 19776233
[TBL] [Abstract][Full Text] [Related]
9. Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections.
Ngo JT; Parkins MD; Gregson DB; Pitout JD; Ross T; Church DL; Laupland KB
Infection; 2013 Feb; 41(1):41-8. PubMed ID: 23292663
[TBL] [Abstract][Full Text] [Related]
10. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
Laupland KB; Parkins MD; Church DL; Gregson DB; Louie TJ; Conly JM; Elsayed S; Pitout JD
J Infect Dis; 2005 Nov; 192(9):1606-12. PubMed ID: 16206075
[TBL] [Abstract][Full Text] [Related]
11. Early deaths in bloodstream infections: a population-based case series.
Kontula KS; Skogberg K; Ollgren J; Järvinen A; Lyytikäinen O
Infect Dis (Lond); 2016; 48(5):379-85. PubMed ID: 26763410
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study.
Al-Hasan MN; Wilson JW; Lahr BD; Eckel-Passow JE; Baddour LM
Am J Med; 2008 Aug; 121(8):702-8. PubMed ID: 18691484
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients.
Meynard JL; Barbut F; Guiguet M; Batisse D; Lalande V; Lesage D; Guiard-Schmid JB; Petit JC; Frottier J; Meyohas MC
J Infect; 1999 May; 38(3):176-81. PubMed ID: 10424798
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population.
Camargo LF; Marra AR; Pignatari AC; Sukiennik T; Behar PP; Medeiros EA; Ribeiro J; Girão E; Correa L; Guerra C; Brites C; Pereira CA; Carneiro I; Reis M; Souza MA; Barata CU; Edmond MB;
Transpl Infect Dis; 2015 Apr; 17(2):308-13. PubMed ID: 25726707
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia.
Meatherall BL; Gregson D; Ross T; Pitout JD; Laupland KB
Am J Med; 2009 Sep; 122(9):866-73. PubMed ID: 19699383
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections.
Wolfe CM; Cohen B; Larson E
J Infect Public Health; 2014; 7(3):224-32. PubMed ID: 24631369
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.
Cheong HS; Kang CI; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
Am J Med; 2008 Aug; 121(8):709-14. PubMed ID: 18691485
[TBL] [Abstract][Full Text] [Related]
19. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study.
Laupland KB; Lyytikäinen O; Søgaard M; Kennedy KJ; Knudsen JD; Ostergaard C; Galbraith JC; Valiquette L; Jacobsson G; Collignon P; Schønheyder HC;
Clin Microbiol Infect; 2013 May; 19(5):465-71. PubMed ID: 22616816
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
Suárez C; Peña C; Tubau F; Gavaldà L; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
